NEOADJUVANT CHEMORADIATION

Clinical trials for NEOADJUVANT CHEMORADIATION explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT CHEMORADIATION trials appear

Sign up with your email to follow new studies for NEOADJUVANT CHEMORADIATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy aims to shrink rectal tumors and save organs

Disease control Not yet recruiting

This study tests whether adding two immunotherapy drugs to radiation therapy can better shrink advanced rectal cancer than standard chemoradiation. About 342 adults with a specific type of rectal cancer will be randomly assigned to one of three treatment groups. The goal is to se…

Matched conditions: NEOADJUVANT CHEMORADIATION

Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

NEOADJUVANT CHEMORADIATION

Get alerted when new NEOADJUVANT CHEMORADIATION trials appear

New combo therapy aims to shrink rectal tumors and save organs